Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04486352
Title A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer (EndoMAP)
Acronym EndoMAP
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.